PROS1 and cancer: Research into targeting the immune system using immunogenic proteins (cytokines, co-stimulatory proteins, tumor neoantigens) as a therapy for solid tumor cancers has rapidly increased recently which has translated into significant progress in the field of cancer vaccines [218].